No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dr. Stephen K. Klasko Is Appointed to the Nuvo Group BOD

Editor: What To Know

  • Klasko is a transformative leader and advocate for a revolution who, as President and CEO of Jefferson Health since 2013, has led one of the nation’s fastest-growing academic health institutions based on his vision of re-imagining healthcare and higher education.
  • I look forward to contributing to the success of the INVU platform in creating a mom-centric experience that connects pregnant women and providers and forges a path toward pregnancy population health.
  • Nuvo is building the foundation of a disruption in pregnancy care delivery—a specialty that has seen little innovation in decades and is being left behind in the movement toward ‘a hospital with no address.

September 1, 2020

Dr. Stephen K. Klasko has been appointed to the Board of Directors of Nuvo Group. The news was announced today. He is President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health.

Dr. Stephen K. Klasko brings a rare combination of experience as a former practicing OB/GYN, a pioneer in envisioning ‘a hospital with no address,’ and the CEO of a major health system at the vanguard of telehealth.

Nuvo is building the foundation of a disruption in pregnancy care delivery—a specialty that has seen little innovation in decades and is being left behind in the movement toward ‘a hospital with no address. Steve’s unparalleled vision, clinical, and operational experience makes him uniquely suited to provide insights, strategic guidance, and market connections that will help Nuvo revolutionize pregnancy care for the 21st century and create extraordinary value for all system stakeholders,” said Oren Oz, Founder and CEO of Nuvo Group.

Nuvo Group shares my vision of what the next generation of healthcare must be—namely ‘healthcare at any address,’ said Dr. Klasko. “In the United States, an emphasis on ‘sick care’ has led to pregnancy being viewed as a disease, defined by a hospital-centric model that has frustrated women at many levels and increased maternal neonatal disparities. Otherwise healthy pregnant women don’t view themselves as patients—and do not want to go where the sickest people are for testing. I look forward to contributing to the success of the INVU platform in creating a mom-centric experience that connects pregnant women and providers and forges a path toward pregnancy population health.”

Dr. Klasko is a transformative leader and advocate for a revolution who, as President and CEO of Jefferson Health since 2013, has led one of the nation’s fastest-growing academic health institutions based on his vision of re-imagining healthcare and higher education. Prior to Jefferson Health, he served as dean of two medical colleges and the leader of three academic health centers.

Dr. Klasko’s own research has focused on physician leadership. After receiving his MBA from the Wharton School of Business of the University of Pennsylvania, he developed research about selecting and educating physicians to be leaders of change. He launched a unique medical education program at the University of South Florida, called SELECT (Scholarly Excellence, Leadership Education, Collaborative Training), to choose and mentor medical students based on emotional intelligence and leadership potential.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy